Table 1.

Demographic and pretreatment clinical characteristics for total sample and for each intervention condition.

	Total Sample	Doctor Only	BRENDA	CBT
	n=194	n=64	n=67	n=63
% Male	74.2%	78.1%	73.1%	71.4%
% Caucasian*	76.2%	78.1%	84.9%	65.1%
% Married	32.3%	33.3%	39.4%	23.8%
% Naltrexone	46.9%	51.6%	46.3%	42.9%
Mean Age	43.7 (10.9)	42.6 (11.4)	44.3 (10.0)	44.2 (11.2)
Mean Years Education	13.8 (2.7)	13.5 (2.8)	14.2 (2.6)	13.7 (2.6)
Mean BDI Score	19.9 (10.2)	19.1 (10.5)	18.7 (9.2)	22.1 (10.7)
Mean Years of Lifetime Use (ETOH)	23.3 (10.6)	23.1 (11.5)	22.9 (10.1)	23.9 (10.3)
Mean Days Used in the Past 30 (ETOH)	19.2 (8.4)	19.1 (7.9)	18.4 (8.5)	20.0 (8.9)

^*p < 0.05; % Caucasian is greater in BRENDA than CBT.